About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study With RO4917523 in Patients With Fragile X Syndrome

A Study With RO4917523 in Patients With Fragile X Syndrome

NCT01015430·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hoffmann-La Roche

Age

18–50

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adult patients, 18 to 50 years of age
Fragile X Syndrome
IQ less than 75
Reliable caregiver

You may not be if

Current psychosis or presumption of psychosis
History of suicidal behavior or considered a high suicidal risk
Severe self-injurious behavior
Any unstable medical condition other than Fragile X Syndrome (e.g. hypertension, diabetes)
Current seizure disorder

The record

StatusCompleted

PhasePhase 2

Taking part40

StartedNov 2009

UpdatedNov 2, 2016

Conditions

Fragile X Syndrome

Where5

Sacramento, California, United States
Decatur, Georgia, United States
Chicago, Illinois, United States